ArticleCureus2025
Regression Modeling of ZAP-X Treatment Time.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate prediction of treatment time is critical in stereotactic radiosurgery (SRS) for optimizing patient scheduling and workflow efficiency. The ZAP-X system (ZAP Surgical Systems, Inc., San Carlos, CA), the newest cranial SRS platform, provides a built-in estimate of treatment time but often underestimates the actual treatment duration. This study aimed to develop a robust predictive model for ZAP-X treatment time, improving accuracy and reliability. Prospective data of 200 patients treated with ZAP-X SRS at Jersey Shore University Medical Center including timing metrics, treatment planning variables, and clinical factors were analyzed. Random Forest regression identified the most critical factors influencing treatment time. Subsequently, Ridge Regression was applied to develop a predictive model, with 10-fold cross-validation used for model tuning and validation. Random Forest analysis identified setup time and gantry time as the most influential variables affecting the treatment duration, followed by the number of beams, number of isocenters, dose, and target number. The Ridge Regression model demonstrated strong predictive performance (R² = 0.984, MAE = 1.94 minutes, RMSE = 2.49 minutes), significantly surpassing the ZAP-X system's internal estimates. The model's accuracy can be attributed to its ability to account for procedural variability, particularly in setup time. The Ridge Regression model provides a highly accurate and interpretable method for predicting ZAP-X treatment time, outperforming the system's internal calculations. This model has immediate clinical utility for improving patient scheduling and resource management in SRS. Future work should focus on validating the model across institutions and adapting it to evolving ZAP-X technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.